Professional Documents
Culture Documents
4 PIC/S PI 023-1
F.4 Aide-Memoire
Inspection of Pharmaceutical Quality
Control Laboratories (PIC/S PI 023-1)
PI 023-1
16 December 2005
F.4
web site: http://www.picscheme.org
Table of Contents
1. Document History . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
2. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
3. Purpose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
4. Scope . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
5. Aide-Memoire . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
6. Revision History . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
F.4
1. Document History
Adoption by the PIC/S committee: 13 September 2005
Entry into force: 1 January 2006
2. Introduction
Inspections of sites involved in testing of medicinal products should be more and
more specific, thorough and conducted under normal working environment.
These inspections may include a complete assessment of laboratory’s conform-
ance with the code of GMP or they may be limited to specific methodology or
aspects of the laboratory. Inspection process of a laboratory involves the assess-
ment of laboratory functions in full operation. Consequently, PIC/S has developed
F.4
the Aide Memoires, which can be considered a good tool for enhancing the
understanding and performance of inspectors.
3. Purpose
3.1. The purpose of this document is to provide guidance for GMP inspectors
to assist in training and preparing for inspections.
3.2. The Aide-Memoire was drafted with the aim of facilitating effective plan-
ning and conducting of GMP inspections of laboratories. The Aide-Memoire
should enhance the efficiency of the GMP inspection and evaluation process.
4. Scope
4.1. This document applies to laboratories for testing of the finished medicinal
products, intermediates, starting materials for the production of medicinal prod-
ucts and in-process controls.
4.2. At the time of issue, this document reflected the current state of the art. It
is not intended to be a barrier to technical innovations or the pursuit of excellence.
5. Aide-Memoire
The Aide Memoire in Annex consists of 9 tables containing general subjects and
items to be investigated during the GMP inspection of laboratories. Some impor-
tant questions and relevant references to the PIC/S documentation are included as
well.
6. Revision History
F.4
Table of Contents
1. General . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
1.1. Test activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
1.2. Activities contracted out (Contract testing). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
3. Documentation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
3.1. General information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
3.2. Laboratory documentation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
3.3. Data traceability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
3.4. Electronic documentation/computerised systems. . . . . . . . . . . . . . . . . . . . . . . . . . 11
4. Personnel . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
4.1. General . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
4.2. Training. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
8. Testing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
8.1. Testing general . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
8.2. Testing of raw materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
8.3. Testing in process, controls (IPC) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
8.4. Testing of intermediates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
F.4
1.3. Qualification for some laboratory apparatuses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
1. General
1. General infor- • Name of the establish- • Who is the contact person
mation ment (name, phone No, e-mail)
• Physical address,
phone No., FAx No. e-
mail
• Postal address
2.2. Suppliers • Suppliers approvals, • Policy for supplier’s quality PIC/S G. 1.2.;
quality contracting assessment defined? 4.14; 5.25
F.4
ensuring • Purchasing control/ • Audits, qualification/ eval- and Annex
vendors evaluation uation made? 2; It. 25; An-
nex 8 It.3
2.3. Self Self inspection / audit sys- • How and by whom per- PIC/S G .
inspection tem and performance formed? 1.2.; 9.1 9.2.;
• How reported? 9.3.
• How are corrective meas-
ures implemented?
• Schedule available and is
adhered to?
2.5. Change System, responsibilities, • How are changes docu- PIC/S G. 1.3.
control follow up actions mented, managed, con- ; Annex 15.
trolled? It.43.
2.6. Risk Risk management method/ • Are all critical parameters PIC/S G.
management approach included? Annex 15.
• How is this related to vali- It..44
dation process?
3. Documentation
3.1. General System description (prepa- • Defined in writing (format, PIC/S G. 4.1.-
information ration, revision. distribu- numbering system, ap- 4.11
tion, archiving) of docu- proval criteria, distribu- Annex 18
mentation (change tion, return, interval for re- It.6.7. - 6.10.
control) vision etc.).
F.4
identity, dedication, data
to be recorded etc)?
Paginated?
4. Personnel
4.1. General Number of employees (to- • The number is adequate? PIC/S G 2.8;
tal); specified to positions • What is the annual aver- 2.9; 6.6.;
and different testing age staff turnover?
F.4
ment in clean room)?
Storage areas (e.g. for doc- • How are the documents/ PIC/S G. 4.8.;
uments, for samples etc.) sensitive instruments pro- 4.9.; 3.44.
tected?
• Are storage conditions
monitored?
• Where is defective equip-
ment stored?
F.4
cation for delivered equip-
ment (URS) exists?
• Relevant checks were
made?
F.4
• Testing kits used?
• How new lots are traced
back to the previous lots?
6.2. Water and Water system/quality • Is the laboratory water sys- Annex 1 to
water systems tem described? PIC/S G.
• How is the laboratory wa- It.35;44
ter prepared?
• Water quality is defined
(SPECS)?
• What is the quality of wa-
ter used for microbiologi-
cal testing?
sampled (SOP)?
F.4
Sampling • How is ampling per-
formed?
• By whom? SOP(s) for sam-
pling available?
• Includes the details on
containers, labelling,
equipment cleaning etc.?)
dure is used?
7.2. Samples Handling of samples • How are the composite PIC/S G. It.
samples blended? 6.4.; and An-
• How are (if applicable) nex 8
samples for testing and It. 6 - 9
contract testing handled
(labelled, transferred, reg-
istered, distributed)?
• SOP(s) available?
Proper accountability of
samples assessed?
• Are there used some con-
F.4
tract facilities?
• Responsibilities defined?
8. Testing
8.1. Testing QC system • Written document availa- PIC/S
general ble? G.6.15-6.21
• Which types of testing PI 012-1,
performed (e.g. microbio- 11.2.
logical, immunological,
chemical etc.)?
Methods • Approved/validated?
• Acceptance limits speci-
fied?
F.4
ment and quality of test-
ing?
• Personnel (operators)
trained?
• Where is it documented?
batches/products de-
fined)?
• Analytical methods are
suitable?
• What is the extend of test-
ing in case of changes?
• Which measures are taken
in case if OOS results were
tested?
F.4
parameters defined in ICH:
• precision (System and
method)
• intermediate precision
• Accuracy,
• Specificity
• Reproduceability
- linearity (range),
- limit of detection,
- limit of quantitation,
- robustness (including so-
lution stability and filter
compatibility)
• Documented in each SOP
or protocol:
• Acceptance criterion for
each parameter defined
and met,
• System suitability test
procedure has been devel-
oped,
• Acceptance criterion for
each system suitability pa-
rameter defined and met.
F.4
Evaluation of OOS results • What is the procedure on
decision related to OOS?
Reasons defined?
9.3. Failures – Company’s procedure (re- • How often can a retest be PI 012-1
Re-testing and testing programme, crite- performed? It.13
Re-sampling ria for re-sampling) • How many times could
testing be repeated (test-
ing into compliance)?
• What are criteria for re-
sampling (e.g. if the sam-
ple was not representa-
tive)?
Note: Some more details and specific items related to testing in chemical, physical-chemi-
cal and microbiological laboratories to be investigated in addition to above described sub-
jects, are involved in Supplements 1 and 2
1.1. Chemical Procedures in place • Up dated? Valid? (see also PIC/S G.6.15.-
testing AIDE Item 3.2.) 6.21
F.4
Volumetric glassware • What is the level of volu- PIC/S G. 3.41.
metric glassware (e.g. pi- 6.5; 6.19
pettes calibration)?
ured?
• Temperature adjusted?
• If not how is result calcu-
lated?
Polarimetry • RM used?
• What is traceability to of-
ficial standards?
• How many readings
made?
Viscosity testing
F.4
• Show me your in-house
calibration programme!
Is there a SOP?
What are the acceptance
criteria and how is it
linked to the external cal-
ibration results?
• How often balances are
calibrated?
Are calibration certifi-
cates available?
1.1 Premises Areas / Sterility testing area • How is the design and PI 012-1
fittings of the area? It.8.1.; 8.3.
• Where are sterility tests
carried out?
• In isolator?
• How is assessed protec-
F.4
tion against microbio-
logical contamination
during aseptic opera-
tions?
• Appropriate instruc-
tions for access into the
critical areas exist?
1.2. Equipment Isolators used for the steril- • IQ, OQ, PQ made? Annex to PIC/S
ity testing Show me the results G. It. 7-9;
(report)! PI 014-1
• Show me the results of
leak test in general
(same as LAF)!
F.4
temperature mapping!
• Calibration of instru-
ment for measure-
ments of humidity was
made?
• How is CO2 (calibration)
tested?
2. Materials
F.4
and how is it calculated
(dryness!)?
3. Testing
F.4
ple during incubation? PI 007-1, 5.2.-
5.5.; 9.9.1.-9.9.2
Growth promotion • Do you have records PI 012-1,
(registration/incuba- It.11.5.
tion)?
• Which micro-organisms
are used?
plan?
• Are there available doc-
uments on pre-qualifi-
cation/re-qualification?
F.4
(SOP)?
• Identification of organ-
isms made?
• What is the time lapse
from fumigation to tak-
ing sample?